Alphabet’s venture arms hold a $2.5B to $3B portfolio of 37 stocks, heavily focused on healthcare and biotech. They recently exited Verve Therapeutics and added positions in Figma and BridgeBio Oncology Therapeutics. Google dominates the search engine market and has seen growth in cloud computing and AI. Figma, a cloud-based design platform, offers collaboration tools that align with Google’s ecosystem. BridgeBio Oncology Therapeutics focuses on developing oncology drugs, complementing Alphabet’s healthcare focus. Many Americans are realizing they can retire earlier than expected by answering three simple questions.

Read more at Yahoo Finance: Alphabet’s Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too?